Back

Tocilizumab mitigates hypercoagulability after out-of-hospital cardiac arrest - results from a randomized controlled trial (IMICA)

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Frontiers in the diagnosis and management of cardiac arrest Cardiac Arrest ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Martin Meyer

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Duration of resuscitation efforts and long-term prognosis following in-hospital cardiac arrest (IHCA)
Mr H. Yonis (Hilleroed, DK)
Abstract Slides Video
Presentation thumbnail
Ischemic signs on the post-resuscitation ECG in absence of STEMI is associated with lower survival. A COACT trial's sub-study
Mrs E. Spoormans (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a nationwide multicentre study
Doctor S. Rasalingam Mork (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Shortening pre-hospital time delay in patients with acute myocardial infarction using a modelling-based narrative intervention with a virtual heart attack experience: a randomized controlled trial
Assistant Professor P. Li (Hong Kong, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Frontiers in the diagnosis and management of cardiac arrest

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources